I. Dogan Et Al. , "Single-agent temozolomide as salvage therapy in heavily pretreated metastatic sarcoma patients," Journal of Cancer Research and Therapeutics , vol.20, no.1, pp.93-97, 2024
Dogan, I. Et Al. 2024. Single-agent temozolomide as salvage therapy in heavily pretreated metastatic sarcoma patients. Journal of Cancer Research and Therapeutics , vol.20, no.1 , 93-97.
Dogan, I., Paksoy, N., & BAŞARAN, M., (2024). Single-agent temozolomide as salvage therapy in heavily pretreated metastatic sarcoma patients. Journal of Cancer Research and Therapeutics , vol.20, no.1, 93-97.
Dogan, İzzet, Nail PAKSOY, And Mert BAŞARAN. "Single-agent temozolomide as salvage therapy in heavily pretreated metastatic sarcoma patients," Journal of Cancer Research and Therapeutics , vol.20, no.1, 93-97, 2024
Dogan, İzzet Et Al. "Single-agent temozolomide as salvage therapy in heavily pretreated metastatic sarcoma patients." Journal of Cancer Research and Therapeutics , vol.20, no.1, pp.93-97, 2024
Dogan, I. Paksoy, N. And BAŞARAN, M. (2024) . "Single-agent temozolomide as salvage therapy in heavily pretreated metastatic sarcoma patients." Journal of Cancer Research and Therapeutics , vol.20, no.1, pp.93-97.
@article{article, author={İzzet DOĞAN Et Al. }, title={Single-agent temozolomide as salvage therapy in heavily pretreated metastatic sarcoma patients}, journal={Journal of Cancer Research and Therapeutics}, year=2024, pages={93-97} }